Skip to main content

VDO Biotech

vdo-biotech

VDO Biotech Co., Ltd. is a high-tech enterprise dedicated to innovative microsphere technologies and the production of a variety of high-quality microsphere products for global customers. Committed to R&D and innovation, they hold 6 authorized patents and 17 pending patents, and have successfully acquired high-tech enterprise certification.

Led by senior scientists from world-renowned universities, VDO's microsphere scientific team has established an advanced technology platform and a continuously innovative R&D system. VDO-Biotech has always adhered to high standards of production management, and their manufacturing facilities have acquired ISO 9001:2015 certification. VDO Biotech’s portfolio covers magnetic microspheres, latex microspheres, colored microspheres, fluorescent microspheres, flow cytometry microspheres, standard microspheres, and microsphere-related services, which can be widely used in molecular diagnosis and immunodiagnosis. VDO has been endorsed by users all over the world for their high-quality products and services and they are constantly creating new legends of core suppliers in the IVD field with higher-quality nano-microsphere products.

VDO Biotech is deeply engaged in the large-scale microsphere production and application for in vitro diagnostics. They not only provide microspheres of uniform and controllable particle size, nano-sized & micro-sized microspheres with high quality and a variety of surface functional groups, but also provide customized services of various types of microspheres, large-scale microsphere conjugation services with antibodies or nucleic acid probes, OEM services for microspheres and intermediates, and complete solutions for microsphere applications.

With the mission of making biological diagnosis more accurate, VDO will continue to move forward, innovate constantly, and strive to become the world's leading supplier of biological diagnostic microspheres. Their dedicated staff is a reliable partner for the solution of any microsphere-related applications!

www.vdobiotech.com

The prices are on request! Contact Us by e-mail info@sobekbio.com

DIMA Biotech

DIMA_Biotech

DIMA Biotechnology Ltd. is a biotech company focusing on preclinical R&D products and services for druggable targets. They plan to complete the preparation of lead antibody molecules for all druggable targets in the next 3-5 years. DIMA Biotech provides multiple pre-prepared lead antibody molecules for each target to help pharmaceutical companies skip the tedious steps of monoclonal antibody platform establishment and lead molecule screening. Therefore,  companies can  have more time to focus on the biological mechanism and developability study of drug targets, thus accelerating the process of new drug R&D.

Over the years, DIMA Biotech has been deeply engaged in developing and optimizing the underlying technology platforms for preclinical research. Currently, they have established two independently developed core technology platforms:

Single/multiple transmembrane protein eukaryotic expression, preparation and purification platforms, apply mammalian cell expression systems, provide ECD or full-length membrane protein products closest to native conformation and functional validation. In addition, DIMA Biotech has developed five major functional full-length transmembrane protein preparation systems, including Membrane Nanoparticle (MNP), Virus-Like Particle (VLP), Exosome (EXO), Detergent and Synthetic Nanodisc. Thousands of drug target protein products are in stock. 
DimAb® High-throughput single B-cell lead antibody molecule discovery platform. DIMA Biotech has completed the preparation and screening of lead antibody molecules against more than 200 drug targets by this platform in just two years. Moreover, they have formed strategic partnerships with several international pharmaceutical enterprises and licensed several drug target molecules. DIMA’s preclinical development strength is widely recognized by the industry. 


www.dimabio.com

The prices are on request! Contact Us by e-mail info@sobekbio.com

CUSABIO

cusabio

CUSABIO is a National High-Tech Enterprise which combines research, production and sales in one. They are dedicated to providing 60,000+ validated antibodies, 8,000+ recombinant proteins, 660+ cytokines and thousands of ELISA kits to global customers in the research fields of cancer, cell biology, immunology, neuroscience, epigenetics, etc. 

What CUSABIO Does:

As a manufacturer of ELISA kits, Exosome isolation kits, antibodies, proteins and related reagents, their only mission is to provide the best products and related custom service to researchers so that they can have a good start for the next breakthrough. CUSABIO's high quality has been guaranteed by many published literatures in all kinds of famous journals, such as Science, Nature, Cell, Developmental Biology, Molecular Cell, Genes & Development, and so on. Now, the publications citing CUSABIO products has reached more than 4,800, with hundreds of publications updating every year.

Kits

CUSABIO has a sound platform for the development of assay kits, mature antigen-antibody research and development systems. Assay kits offered by CASABIO are mainly two types, including ELISA kits and exosome isolation kits. They are proficient in a variety of ELISA technologies such as the double antibody sandwich method, double antigen sandwich method, direct competition ELISA method, indirect competition ELISA blocking method, indirect ELISA method, and other methods. And fine affinity purification technology for the production of Exosome Isolation Kits is also adopted.

Combined with their diagnostic kits development team, CUSABIO is able to develop ELISA kits with clinical diagnostic levels and make the quality in the leading place worldwide. Exosomes have been one of the research hotspots in recent years, and the separation technology of exosomes has been constantly updated and improved. After continuous improvement and repeated testing, CUSABIO has also developed high purity, high yield, and high-efficiency exosome isolation kits. CUSABIO now offers a broad range of ELISA kits covering over 6,000 different assay targets and two Cell Supernatant Exosome Isolation Kits.

Antibodies

CUSABIO offers 60,000+ antibodies that are specific to a variety of species and can be used in multiple applications. Furthermore, the number of CUSABIO antibodies is continuing to grow at a rate of 1000 per year.

As an original manufacturer, CUSABIO designs, produces and validates every antibody in-house. Besides advanced experimental apparatus, CUSABIO antibody line also has a professional technical team, so CUSABIO has succeeded in setting up many technology platforms. At present CUSABIO antibodies can be applied in ELISA, WB, IHC/ICC, IF, IP/Co-IP, ChIP and FC. 

Proteins

CUSABIO Protein Expression Platform has established four recombinant expression systems from prokaryotic (E.coli) to eukaryotic (Yeast, mammalian cell and insect baculovirus), and has also built unique in-vitro E.coil expression system, which enables them to express transmembrane proteins that are usually difficult to express.

CUSABIO currently has 70 native proteins, 100 small molecule antigens, 320 active proteins, 1000+ recombinant proteins in stock, 5700+ developed recombinant proteins, 10,000+ cDNA clones, 36,000+ transmembrane proteins, 500,000+ semi-customized recombinant proteins. 

Custom Service

Given the specificity of each experiment, CUSABIO provides the latest and comprehensive custom services to meet their customers request, including phage display service, antibody service, protein service, gene synthesis service and oligo synthesis service. CUSABIO is very pleased to assist their customers worldwide with all passions and great efforts.

www.cusabio.com

The prices are on request! Contact Us by e-mail info@sobekbio.com

SRGAP1 Antibody CSB-PA948154



The add to cart button will appear once you select the values above

Specifications

100ul / 50ul

Classification:

Polyclonal Antibody

Alternative names:

4930572H05Rik antibody; ARHGAP13 antibody; FLJ22166 antibody; KIAA1304 antibody; RGD1566260 antibody; Rho GTPase activating protein 13 antibody; Rho GTPase-activating protein 13 antibody; SLIT ROBO Rho GTPase activating protein 1 antibody; SLIT-ROBO Rho GTPase-activating protein 1 antibody; SRGAP 1 antibody; srGAP1 antibody; SRGP1_HUMAN antibody

Research area:

Neuroscience

Species reactivity:

Human, Mouse

Antigen species:

Homo sapiens (Human)

Host species:

Rabbit

Clonality:

Polyclonal

Isotype:

IgG

Antigen:

Synthetic peptide of Human SRGAP1

Target name:

SRGAP1

Purification method:

Antigen affinity purification

Buffer:

-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol

Conjugate:

Non-conjugated

Form:

Liquid

Tested applications:

ELISA, WB, IHC

Storage:

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

More info:

Email: info@sobekbio.com

Orders:

Email: orders@sobekbio.com